Endurant Capital Management LP Molecular Templates, Inc. Transaction History

Endurant Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $254,532 - $1.08 Million	-314,238 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $104,109 - $189,414	45,863 Added 17.09%	314,238 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $1.16 Million - $2.37 Million	-345,255 Reduced 56.26%	268,375 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $776,733 - $1.06 Million	-134,383 Reduced 17.97%	613,630 $4.12 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $302,266 - $480,843	38,653 Added 5.45%	748,013 $5.85 Million

Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $262,331 - $395,043	28,117 Added 4.13%	709,360 $8.95 Million
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $2.19 Million - $3.16 Million	258,456 Added 61.13%	681,243 $6.4 Million
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $1.93 Million - $2.78 Million	192,970 Added 83.97%	422,787 $4.62 Million
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $2.82 Million - $4.05 Million	229,817 New	229,817 $3.17 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $65.4M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.